En hemodiálisis y con calcificación coronaria, consumir suplemento de vitamina K2, comparado a placebo, no modifico las calcificaciones, tampoco redujo eventos cardiovasculares, ni mostró algo positivo
Randomized Controlled Clinical Trial of the Effect of Treatment with Vitamin K2 on Vascular Calcification in Hemodialysis Patients (Trevasc-HDK).
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jul 2023 – May 2025Where it's discussed
-
X / Twitter26 posts
-
YouTube6 videos
-
Facebook2 posts
-
News2 articles
AI synopsis
What people are saying
Discussions underscore skepticism about the study's outcome, with posts like 'no beneficial effect' and 'did not modify calcifications,' highlighting disappointment or validation of prior doubts. Words such as 'no effect' and 'did not reduce' create a dismissive tone, while some comments suggest a curiosity about broader implications but do not signal strong engagement or excitement.
Most discussions clearly reflect skepticism or disappointment toward the study's findings that vitamin K2 does not reduce vascular calcification in hemodialysis patients.
The posts show neutral interest levels, with some curiosity about related topics but little enthusiasm for the specific results.
Some posts elaborate on the methodology or implications, indicating moderate engagement, but few participants delve deeply into alternative interpretations.
The overall tone suggests limited impact, as participants acknowledge the negative results but do not see immediate clinical significance or shifts in practice.
Abstract in brief
- The study was a randomized controlled trial examining whether vitamin K2 supplementation could slow down vascular calcification in hemodialysis patients, but after 18 months, there was no significant difference in coronary artery calcification scores between the vitamin K2 group and the control group.
- Although vitamin K2 reduced levels of dephosphorylated undercarboxylated MGP (dpucMGP), a marker related to vitamin K deficiency, it did not lead to improvements in other measures like aortic valve calcification, arterial stiffness, or major cardiac events.
- Overall, the study concluded that vitamin K2 supplementation at the dose and duration used did not have a beneficial effect on reducing vascular calcification or related cardiovascular outcomes in hemodialysis patients.
Top posts
Most liked on X and BlueskyYet another clinical trial finds that vitamin K does not seem to reverse or slow calcification of the coronary arteries or aortic valve. The study used vitamin K2 (MK-7; 360 ug 3x per week) and involved hemodialysis patients. https://t.co/vkeNmGe46c https://t.co/5xQUGV3148
Randomized Controlled Clinical Trial of the Effect of Treatment with Vitamin K2 on #Vascular #Calcification in #Hemodialysis Patients (Trevasc-HDK) #VisualAbstract by @thana_susan https://t.co/VWsq64v5z5 https://t.co/Y0NQCyrNIZ
Vitamin K in #CKD : A Game-Changer or By-Stander https://t.co/qhLSZty9qP Original Article: https://t.co/Q3hVWknZtU #KIRCommentary #VitaminK https://t.co/QWMN9Tx9kQ
RT @ISNkidneycare:
All mentions
Vitamin K2 and Vascular Calcification in Hemodialysis Patients
This study examined whether vitamin K2 supplementation could slow vascular calcification in hemodialysis patients. After 18 months, there was no significant reduction in coronary artery calcification or other…
The Effectiveness of Daily Vitamin K2 on Vascular Calcification
Vitamin K2 has numerous health benefits, especially its impact on blood vessels. Studies show K2 MK7 may halt artery calcification, but a recent trial found no significant benefit in reducing vascular calcification in…
Vitamin K2 and Vascular Calcification in Hemodialysis Patients
This study examined whether vitamin K2 supplementation can reduce vascular calcification in hemodialysis patients. After 18 months, no significant differences in coronary artery calcification or cardiac outcomes were…
Vitamin K2 and Vascular Calcification in Hemodialysis Patients
This video discusses a clinical trial examining the effect of vitamin K2 supplementation on vascular calcification in hemodialysis patients. Despite reducing markers of deficiency, it did not significantly impact…
Vitamin K2 and Vascular Calcification in Hemodialysis Patients
This study examined whether vitamin K2 supplementation could slow vascular calcification in hemodialysis patients. Results showed no significant reduction in calcification scores or major cardiac events after 18 months…
Exploring Vitamin K2: Effects on Bone and Heart Health
In this video, I dive deep into the science behind Vitamin K2 and its impact on bone health and heart health. I will unpack its key functions, including maintaining bone health and preventing arterial calcium buildup…
@DoctorTro Do you know any study about k2 and atherosclerosis reduction? Mainly soft plaques? I was looking forward to see the results of vitak cac trial https://t.co/bDEYNP3Znw. This study below didn't demonstrate any beneficial on vascular calcification. https://t.co/WTISPN90zV
RT @JonathanNefro: En hemodiálisis y con calcificación coronaria, consumir suplemento de vitamina K2, comparado a placebo, no modifico las…
RT @JonathanNefro: En hemodiálisis y con calcificación coronaria, consumir suplemento de vitamina K2, comparado a placebo, no modifico las…
RT @JonathanNefro: En hemodiálisis y con calcificación coronaria, consumir suplemento de vitamina K2, comparado a placebo, no modifico las…
RT @JonathanNefro: En hemodiálisis y con calcificación coronaria, consumir suplemento de vitamina K2, comparado a placebo, no modifico las…
RT @JonathanNefro: En hemodiálisis y con calcificación coronaria, consumir suplemento de vitamina K2, comparado a placebo, no modifico las…
RT @JonathanNefro: En hemodiálisis y con calcificación coronaria, consumir suplemento de vitamina K2, comparado a placebo, no modifico las…
RT @JonathanNefro: En hemodiálisis y con calcificación coronaria, consumir suplemento de vitamina K2, comparado a placebo, no modifico las…
RT @JonathanNefro: En hemodiálisis y con calcificación coronaria, consumir suplemento de vitamina K2, comparado a placebo, no modifico las…
RT @JonathanNefro: En hemodiálisis y con calcificación coronaria, consumir suplemento de vitamina K2, comparado a placebo, no modifico las…
RT @JonathanNefro: En hemodiálisis y con calcificación coronaria, consumir suplemento de vitamina K2, comparado a placebo, no modifico las…
RT @JonathanNefro: En hemodiálisis y con calcificación coronaria, consumir suplemento de vitamina K2, comparado a placebo, no modifico las…
RT @JonathanNefro: En hemodiálisis y con calcificación coronaria, consumir suplemento de vitamina K2, comparado a placebo, no modifico las…
RT @JonathanNefro: En hemodiálisis y con calcificación coronaria, consumir suplemento de vitamina K2, comparado a placebo, no modifico las…
RT @JonathanNefro: En hemodiálisis y con calcificación coronaria, consumir suplemento de vitamina K2, comparado a placebo, no modifico las…
En hemodiálisis y con calcificación coronaria, consumir suplemento de vitamina K2, comparado a placebo, no modifico las calcificaciones, tampoco redujo eventos cardiovasculares, ni mostró algo positivo
RT @MorganPfiffner: Yet another clinical trial finds that vitamin K does not seem to reverse or slow calcification of the coronary arteries…
RT @ISNkidneycare:
RT @MorganPfiffner: Yet another clinical trial finds that vitamin K does not seem to reverse or slow calcification of the coronary arteries…
Yet another clinical trial finds that vitamin K does not seem to reverse or slow calcification of the coronary arteries or aortic valve. The study used vitamin K2 (MK-7; 360 ug 3x per week) and involved hemodialysis patients. https://t.co/vkeNmGe46c https://t.co/5xQUGV3148
RT @KIReports: Vitamin K in #CKD : A Game-Changer or By-Stander https://t.co/qhLSZty9qP Original Article: https://t.co/Q3hVWknZtU #KIRCo…
Vitamin K in #CKD : A Game-Changer or By-Stander https://t.co/qhLSZty9qP Original Article: https://t.co/Q3hVWknZtU #KIRCommentary #VitaminK https://t.co/QWMN9Tx9kQ
RT @KIReports: Randomized Controlled Clinical Trial of the Effect of Treatment with Vitamin K2 on #Vascular #Calcification in #Hemodialysis…
RT @KIReports: Randomized Controlled Clinical Trial of the Effect of Treatment with Vitamin K2 on #Vascular #Calcification in #Hemodialysis…
Randomized Controlled Clinical Trial of the Effect of Treatment with Vitamin K2 on #Vascular #Calcification in #Hemodialysis Patients (Trevasc-HDK) #VisualAbstract by @thana_susan https://t.co/VWsq64v5z5 https://t.co/Y0NQCyrNIZ